Improving Ascertainment of Risk Factors for HIV Infection: Results of a Group-Randomized Evaluation

Abstract

To allow appropriate allocation of prevention and care funding, HIV/AIDS surveillance data must include risk factor information, currently available for less than 70% of cases reported in the United States. The authors evaluated an intervention consisting of provider training and materials to improve risk factor reporting. Facilities were matched prior to randomization to intervention or control, and generalized linear mixed models were used to test for an intervention effect. Twenty-one percent of cases from intervention facilities and 33.4% from control facilities (p = .09) were reported without any risk factor information. The pre—post difference (20.7% for intervention and 36.0% for control) was not significant among HIV cases (p = .11) nor among AIDS cases (p = .12; 21.3% for intervention and 31.1% for control). The methods the authors’ evaluated may need to be combined with other approaches and/or alternative classification schemes to significantly reduce the percentage of cases reported to surveillance without risk factor information.

Keywords

HIV/AIDS surveillance risk factors evaluation group-randomized trial

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. 1999. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recommendations and Reports 48:1-28.

---. 2006. HIV/AIDS surveillance report, 2005. Vol. 17. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

Donner, A. , and N. Klar. 2000. Design and analysis of cluster randomization trials in health research. London: Arnold.

Green, T.A. 1998. Using surveillance data to monitor trends in the AIDS epidemic. Statistics in Medicine 17:143-54.

Henry J. Kaiser Family Foundation. February 2005. Federal funding for HIV/AIDS: The FY 2006 Budget. HIV/AIDS Policy Fact Sheet. Available at http://www.kff.org/hivaids/index.cfm (accessed February 8, 2006).

Klevens, R.M. , Fleming, P.L. , J.J. Neal , J. Li , and The Mode of Transmission Validation Study Group. 1999. Is there really a heterosexual AIDS epidemic in the United States? Findings from a multistate validation study, 1992-1995. American Journal of Epidemiology 149:75-84.

Lee, L.M. , M.T. McKenna , and R.S. Janssen. 2003. Classification of transmission risk in the national HIV/AIDS surveillance system. Public Health Reports 118:400-7.

Murray, D.M. 1998. Design and analysis of group-randomized trials. New York: Oxford University Press.

Murray, D.M. , and J.L. Blitstein. 2003. Methods to reduce the impact of intraclass correlation in group-randomized trials. Evaluation Review 27:79-103.

10.

Murray, D.M. , P.J. Hannan , S.P. Pals , R.G. McCowen , W.L. Baker , and J.L. Blitstein. 2006. A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial. Statistics in Medicine 25:375-88.